Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Vitamin D in Pediatric Crohn's Disease ( ViDiPeC-2 )
Sponsor: Jantchou Prevost
Summary
The purpose of this study is to determine if vitamin D as an adjuvant therapy can improve the outcome (i.e. fewer relapses) and the quality of life, including levels of physical activity, in children diagnosed Crohn's disease (CD).
Official title: A Pragmatic Randomized Controlled Trial on High Dose Vitamin D to Prevent Relapses of Crohn's Disease in Children
Key Details
Gender
All
Age Range
4 Years - 18 Years
Study Type
INTERVENTIONAL
Enrollment
55
Start Date
2020-02-07
Completion Date
2023-09-29
Last Updated
2026-10-21
Healthy Volunteers
No
Conditions
Interventions
vitamin D3
3000 or 4000 UI/ day: Weight at inclusion \< 40 kg : 1 ml per day of the selected concentration at induction and 1ml per day of the selected concentration at maintenance. Weight at inclusion ≥ 40 kg : 1 ml per day of the selected concentration at induction and 1 ml per day of the selected concentration at maintenance 600 UI/ day: Weight at inclusion \< 40 kg :1 ml per day of the selected concentration (600 IU) at induction and 1 ml per day of the selected concentration (600 IU) at maintenance. Weight at inclusion ≥ 40 kg : 1 ml per day of the selected concentration (600 IU) at induction and 1 ml per day of the selected concentration (600 IU) at maintenance
Locations (7)
Stollery Children's Hospital
Edmonton, Alberta, Canada
BC Children's Hospital
Vancouver, British Columbia, Canada
Children's Hospital
Winnipeg, Manitoba, Canada
McMaster University
Hamilton, Ontario, Canada
London Health Sciences Centre
London, Ontario, Canada
Montreal Children's Hospital
Montreal, Quebec, Canada
CHU Sainte-Justine
Montreal, Quebec, Canada